New drug trial for painful skin condition halted early
NCT ID NCT05905783
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called izokibep for people with moderate to severe hidradenitis suppurativa, a chronic skin condition causing painful lumps. The trial aimed to see if izokibep could reduce skin abscesses and inflammation. It included 258 adults who had not responded to other treatments. The study was terminated early, so final results are not available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinical Research Site
Birmingham, Alabama, 35233, United States
-
Clinical Research Site
Scottsdale, Arizona, 85255, United States
-
Clinical Research Site
Scottsdale, Arizona, 85260, United States
-
Clinical Research Site
Fayetteville, Arkansas, 72703, United States
-
Clinical Research Site
Encino, California, 91436, United States
-
Clinical Research Site
Fountain Valley, California, 92708, United States
-
Clinical Research Site
Fremont, California, 94538, United States
-
Clinical Research Site
Los Angeles, California, 90045, United States
-
Clinical Research Site
Santa Monica, California, 90404, United States
-
Clinical Research Site
Boca Raton, Florida, 33486, United States
-
Clinical Research Site
Brandon, Florida, 33511, United States
-
Clinical Research Site
Coral Gables, Florida, 33134, United States
-
Clinical Research Site
Hollywood, Florida, 33021, United States
-
Clinical Research Site
Tampa, Florida, 33607, United States
-
Clinical Research Site
Tampa, Florida, 33613, United States
-
Clinical Research Site
Atlanta, Georgia, 30315, United States
-
Clinical Research Site
Sandy Springs, Georgia, 30328, United States
-
Clinical Research Site
Savannah, Georgia, 31419, United States
-
Clinical Research Site
Springfield, Illinois, 62702, United States
-
Clinical Research Site
Indianapolis, Indiana, 46250, United States
-
Clinical Research Site
Plainfield, Indiana, 46168, United States
-
Clinical Research Site
Topeka, Kansas, 66614, United States
-
Clinical Research Site
Murray, Kentucky, 42071, United States
-
Clinical Research Site
Baton Rouge, Louisiana, 70808, United States
-
Clinical Research Site
Baton Rouge, Louisiana, 70809, United States
-
Clinical Research Site
New Orleans, Louisiana, 70115, United States
-
Clinical Research Site
Largo, Maryland, 20774, United States
-
Clinical Research Site
Boston, Massachusetts, 02215, United States
-
Clinical Research Site
Canton, Michigan, 48187, United States
-
Clinical Research Site
Troy, Michigan, 48084, United States
-
Clinical Research Site
Lebanon, New Hampshire, 03766, United States
-
Clinical Research Site
New York, New York, 10128, United States
-
Clinical Research Site
Charlotte, North Carolina, 28277, United States
-
Clinical Research Site
Boardman, Ohio, 44512, United States
-
Clinical Research Site
Mason, Ohio, 45040, United States
-
Clinical Research Site
Springfield, Ohio, 45505, United States
-
Clinical Research Site
Portland, Oregon, 97223, United States
-
Clinical Research Site
Hershey, Pennsylvania, 17033, United States
-
Clinical Research Site
Pittsburgh, Pennsylvania, 15213, United States
-
Clinical Research Site
Sugarloaf, Pennsylvania, 18249, United States
-
Clinical Research Site
Thompson's Station, Tennessee, 37179, United States
-
Clinical Research Site
Arlington, Texas, 76011, United States
-
Clinical Research Site
Frisco, Texas, 75034, United States
-
Clinical Research Site
Pflugerville, Texas, 78660, United States
-
Clinical Research Site
San Antonio, Texas, 78218, United States
-
Clinical Research Site
The Woodlands, Texas, 77380, United States
-
Clinical Research Site
Webster, Texas, 77598, United States
-
Clinical Research Site
Springville, Utah, 84663, United States
-
Clinical Research Site
West Jordan, Utah, 84088, United States
-
Clinical Research Site
Charlottesville, Virginia, 22908, United States
-
Clinical Research Site
Edmonton, Alberta, T6G1C3, Canada
-
Clinical Research Site
Edmonton, Alberta, T6H4J8, Canada
-
Clinical Research Site
Winnipeg, Manitoba, R3M3Z4, Canada
-
Clinical Research Site
North Bay, Ontario, P1B 3Z7, Canada
-
Clinical Research Site
Peterborough, Ontario, K9J5K2, Canada
-
Clinical Research Site
Toronto, Ontario, M2N3A6, Canada
-
Clinical Research Site
Toronto, Ontario, M4W2N4, Canada
-
Clinical Research Site
Toronto, Ontario, M5A3R6, Canada
-
Clinical Research Site
Waterloo, Ontario, N2J1C4, Canada
-
Clinical Research Site
Saskatoon, Saskatchewan, S7K2C1, Canada
-
Clinical Research Site
Dijon, Bourgogne-Franche-Comté, 21000, France
-
Clinical Research Site
Montpellier, Occitanie, 34090, France
-
Clinical Research Site
Nantes, Pays de la Loire Region, 44000, France
-
Clinical Research Site
Toulon, 83000, France
-
Clinical Research Site
Darmstadt, Hesse, 64283, Germany
-
Clinical Research Site
Bad Bentheim, Lower Saxony, 48455, Germany
-
Clinical Research Site
Mainz, Rhineland-Palatinate, 55128, Germany
-
Clinical Research Site
Leipzig, Saxony, 04103, Germany
-
Clinical Research Site
Kiel, Schleswig-Holstein, 24148, Germany
-
Clinical Research Site
Debrecen, Hajdú-Bihar, 4032, Hungary
-
Clinical Research Site
Zalaegerszeg, Zala County, 8900, Hungary
-
Clinical Research Site
Budapest, 1036, Hungary
-
Clinical Research Site
Fukuoka, Fukoka Prefecture, 814-0180, Japan
-
Clinical Research Site
Kitakyushu, Fukuoka, 807-8555, Japan
-
Clinical Research Site
Obihiro, Hokkaido Prefecture, 080-0013, Japan
-
Clinical Research Site
Sapporo, Hokkaido Prefecture, 060-0063, Japan
-
Clinical Research Site
Kawasaki, Kanagawa, 216-8511, Japan
-
Clinical Research Site
Yokohama, Kanagawa, 236-0004, Japan
-
Clinical Research Site
Kyoto, Kyoto, 602-8566, Japan
-
Clinical Research Site
Osaka, Osaka, 589-8511, Japan
-
Clinical Research Site
Shinjuku-Ku, Tokyo, 160-0023, Japan
-
Clinical Research Site
tabashi City, Tokyo, 173-8610, Japan
-
Clinical Research Site
Nishinomiya, 663-8186, Japan
-
Clinical Research Site
Krakow, Lesser Poland Voivodeship, 30-001, Poland
-
Clinical Research Site
Krakow, Lesser Poland Voivodeship, 90-436, Poland
-
Clinical Research Site
Wroclaw, Lower Silesian Voivodeship, 50-566, Poland
-
Clinical Research Site
Wroclaw, Lower Silesian Voivodeship, 51-318, Poland
-
Clinical Research Site
Lublin, Lublin Voivodeship, 20-573, Poland
-
Clinical Research Site
Katowice, Silesian Voivodeship, 40-611, Poland
-
Clinical Research Site
Ożarowice, Silesian Voivodeship, 42-624, Poland
-
Clinical Research Site
Sosnowiec, Silesian Voivodeship, 41-218, Poland
-
Clinical Research Site
Lodz, Łódź Voivodeship, 90-265, Poland
-
Clinical Research Site
Seville, Andalusia, 41009, Spain
-
Clinical Research Site
Palma de Mallorca, Balearic Islands, 07120, Spain
-
Clinical Research Site
Badalona, Catalonia, 08916, Spain
-
Clinical Research Site
Barcelona, Catalonia, 08041, Spain
-
Clinical Research Site
Manises, Valencia, 46940, Spain
-
Clinical Research Site
Madrid, 28031, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could childhood trauma fuel skin inflammation?
- Head-to-Head: which pill tames hidradenitis suppurativa best?
- Skin disease evolution under the microscope: a 17-Year look at what drives severity
- Could early treatment tame a painful skin condition?
- New pill shows promise for controlling painful skin condition in long-term trial
- New shot could ease painful skin condition